GENMAB A/S: Financial statements 2023
CVR: 21023884
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
GENMAB A/S (CVR 21023884) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 16,474,000,000 and a net result of DKK 4,352,000,000 compared with DKK 5,522,000,000 the year before. That is an increase of 12.9% compared with the year before. The profit margin was 26.4%. Equity in the 2023 report amounted to DKK 31,610,000,000. The solvency ratio was 89.6%. The company had 2,011 employees in the financial year.
- Revenue
- DKK 16,474,000,000
- Profit/Loss
- DKK 4,352,000,000
- Equity
- DKK 31,610,000,000
- Total Assets
- DKK 35,289,000,000
- Employees
- 2,011
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 16.5 mia. | - | 4.4 mia. | 31.6 mia. | 2011 |
| 2022 | 14.6 mia. | - | 5.5 mia. | 27.4 mia. | 313 |
| 2021 | 8.5 mia. | - | 3 mia. | 22.2 mia. | 235 |
| 2020 | 10.1 mia. | - | 4.8 mia. | 19.1 mia. | - |
| 2019 | 5.4 mia. | - | 2.2 mia. | 14 mia. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
GENMAB A/S has published its interim report for the period January 7, 2023 – September 30, 2023.
GENMAB A/S has published its interim report for the period January 1, 2023 – June 30, 2023.
GENMAB A/S has published its interim report for the period January 1, 2023 – March 31, 2023.
As of April 10, 2023, Suzana Sturlini Couto has left the board of directors of GENMAB A/S.
GENMAB A/S has published its annual report for 2022. Revenue came to DKK 14,595,000,000, and the net result was DKK 5,522,000,000.
As of January 1, 2023, Judith Viviana Klimovsky has stepped down as director of GENMAB A/S.
As of January 1, 2023, Anthony Mancini has stepped down as director of GENMAB A/S.
As of January 1, 2023, Tahamtan Ahmadi has stepped down as director of GENMAB A/S.
About GENMAB A/S
GENMAB A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GFKJUS 519 ApS. The management consists of Jan van de Winkel and Anthony Michael Pagano. The board consists of Deirdre Patrice Connelly (chair), Pernille Lyngvold Erenbjerg, Anders Gersel Pedersen and Elizabeth Grimes O’Farrell. The company is owned by BLACKROCK, INC. and Darwin Global Management Limited. The company has 676 employees (2026). In 2025, the company reported revenue of USD 3,720,000,000 and a net result of USD 963,000,000 compared with DKK 7,844,000,000 the year before. Equity in the 2025 report amounted to USD 5,847,000,000.